FierceBiotechFierceBiotechResearchFierceBiotechITFierceVaccinesFiercePharmaFiercePharmaManufacturing   FierceHealthcare

Free Newsletter

About | View Sample | Privacy

VaxDesign offers an alternative to animal studies


Time magazine profiles the work of VaxDesign, a five-year-old biotech company that has developed simulated human immune systems, mixing blood cells and faux tissue into a special construct that can test a vaccine--"clinical trials in a test tube." Their idea is that a simulated immune system can replace time-consuming animal tests, which have limited value in their ability to indicate an actual human response. Better indications of efficacy at an earlier stage might help prevent large-scale human trials that fail to reach their intended endpoints--as in the recent fiasco involving Merck's AIDS vaccine, which may have heightened volunteers' risk of contracting AIDS. With VaxDesign's MIMIC system, the small immune systems test whether a vaccine will spur the needed antibodies into action.

"The information you get from this type of test is far and beyond what you'd get out of a mouse study," says Michael Rivard, vice president of corporate development at VaxDesign, "both because it's humans and because you can see the effect across a spectrum of genotypes."

- read the article in Time

Related Articles:
UK stops some animal testing. Report
How useful is animal testing for predicting human outcomes? Report

More stories about Vaccine   VaxDesign   cancer vaccine   Michael Rivard  


Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

To combat spam, please enter the code in the image.